会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明申请
    • 4-(1-(SULFONYL)-1H-INDOL-2-YL)-4-(HYDROXY)-CYCLOHEXA-2,5-DIENONE COMPOUNDS AND ANALOGS THEREOF AS THERAPEUTIC AGENTS
    • 4-(1-(磺酰基)-1H-吲哚-2-基)-4-(羟基) - 环己基-2,5-二酮化合物及其作为治疗剂的模拟物
    • WO2004056361A1
    • 2004-07-08
    • PCT/GB2002/005842
    • 2002-12-20
    • CANCER RESEARCH TECHNOLOGY LIMITEDSTEVENS, Malcolm, Francis, GrahamWESTWELL, Andrew, DavidPOOLE, Tracey, DawnWELLS, GeoffreyBERRY, Jane, Marie
    • STEVENS, Malcolm, Francis, GrahamWESTWELL, Andrew, DavidPOOLE, Tracey, DawnWELLS, GeoffreyBERRY, Jane, Marie
    • A61K31/404
    • C07D209/12A61K31/404
    • This invention pertains to certain 4-(1-(sulfonyl)-1H-indol-2-yl)-4-(hydroxy)-cyclohexa-2,5-dienone compounds, and analogs thereof, including compounds of the following formula, which are, inter alia, antiproliferative agents, anticancer agents, and/or thioredoxin/thioredoxin reductase inhibitors: formula (I) wherein: Ar is a 1-(sulfonyl)-1H-indol-2-yl group; the bond marked α is independently: (a) a single bond; or: (b) a double bond; the bond marked β is independently: (a) a single bond; or: (b) a double bond; the group -OR O is independently: (a) -OH; (b) an ether group (e.g., -OMe); or: (c) an acyloxy (i.e., reverse ester) group (e.g., -OC(=O)Me); each of R 2 , R 3 , R 5 , and R 6 , is independently a ring substituent and is: (a) H; (b) a monovalent monodentate substituent; or: (c) a ring substituent which, together with an adjacent ring substituent, and together with the ring atoms to which these ring substituents are attached, form a fused ring; and pharmaceutically acceptable salts, esters, amides, solvates, hydrates, and protected forms thereof. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, for example, in the treatment of proliferative conditions, (e.g., cancer), and/or conditions mediated by thioredoxin/thioredoxin reductase.
    • 本发明涉及某些4-(1-(磺酰基)-1H-吲哚-2-基)-4-(羟基) - 环己-2,5-二烯酮化合物及其类似物,包括下式的化合物,其中 尤其是抗增殖剂,抗癌剂和/或硫氧还蛋白/硫氧还蛋白还原酶抑制剂:式(I)其中:Ar是1-(磺酰基)-1H-吲哚-2-基; 标记为α的键独立:(a)单键; 或(b)双键; 标记为β的债券是独立的:(a)单一债券; 或(b)双键; 基团-OR 0独立地为:(a)-OH; (b)醚基(例如-OMe); 或(c)酰氧基(即反酯)基团(例如-OC(= O)Me); R 2,R 3,R 5和R 6各自独立地为环取代基,并且是:(a)H; (b)一价单齿取代基; 或者:(c)环取代基,与环相邻的取代基一起以及与这些环取代基连接的环原子一起形成稠环; 和其药学上可接受的盐,酯,酰胺,溶剂合物,水合物及其保护形式。 本发明还涉及包含这些化合物的药物组合物,以及这些化合物和组合物在体外和体内例如用于治疗增殖性疾病(例如癌症)和/或由 硫氧还蛋白/硫氧还蛋白还原酶。